A cross sectional study of Quality of Life in long-term adult survivors after allogeneic hematopoietic stem cell transplantation

A cross sectional study of Quality of Life in long-term adult survivors after allogeneic hematopoietic stem cell transplantation - QOL in adult survivors after hematopoietic stem cell transplantation

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000009545

Enrollment

300

Registered

2012-12-15

Start date

2012-12-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hematopoietic stem cell trans- plantation targeted diseases such as hematological diseases

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1)Patients who aged 16 or above at transplantation and 20 or above at study. (2)Patients who were transplanted at adult department. (3)Patients who survived for two years and above after last transplantation without relapse. (4)Patients who signed a written informed consents. (5)Patients who can read Japanese questionnaire.

Exclusion criteria

Exclusion criteria: (1)Patients who disapproved of TRUMP search. (2)Patients who are disqualified by his attending physician.

Design outcomes

Primary

Measure	Time frame
We will examine QOL of adult survivors which assessed by SF-36, FACT-BMT and VAS described below. (1)SF-36: Compare QOL of patients with that of same sex, coeval national certified value. (2)FACT-BMT: Examine factors associated with QOL. (3)VAS: Compare VAS of patients and their attending physician and examine associated factors. (4)Factors which are associated with QOL Donor and type of transplantation Conditioning regimens and total body irradiation *Years after transplantation, reintegration into society, connubiality and restoration of gonadal function (5)Compare background factors of patients who are engaged in this study with who disapproved or unable to explain this study. (6)Compare patients who are included in this study and patients who are included in the pediatric study.	—

Measure

Time frame

We will examine QOL of adult survivors which assessed by SF-36, FACT-BMT and VAS described below. (1)SF-36: Compare QOL of patients with that of same sex, coeval national certified value. (2)FACT-BMT: Examine factors associated with QOL. (3)VAS: Compare VAS of patients and their attending physician and examine associated factors. (4)Factors which are associated with QOL *Donor and type of transplantation *Conditioning regimens and total body irradiation *Years after transplantation, reintegration into society, connubiality and restoration of gonadal function (5)Compare background factors of patients who are engaged in this study with who disapproved or unable to explain this study. (6)Compare patients who are included in this study and patients who are included in the pediatric study.

—

Countries

Japan

Contacts

Public ContactKumi Oshima, M.D.

Hiroshima University Research Institute for Radiation Biology and Medicine Department of Hematology and Oncology, Research Center for Radiation Casualty Medicine

kumioshima-tky@umin.ac.jp082-257-5861

Outcome results